Congressional Briefing on Vaccine Development: Innovating for the Future

The unprecedented rate of vaccine development for COVID-19 demonstrates how public-private partnerships in innovation can produce fast and effective results. This model for vaccine development and use of vaccine development platforms that can be used with minor tailoring for each new virus or variant is a critical next step to ensure a worldwide pandemic never occurs again.

Please join us to hear from a team of experts about innovative vaccine development options that would fortify our country against any future diseases and how these innovations can be used for the COVID variants currently emerging.

Upcoming Events